(PO07-51-22) Evaluation of Perceived Stress and Sleep Improvement With the Dairy Bioactive Lactium®

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

JM

Joanna Moro, PhD
– Biocatives clinical trials specialist, Ingredia, Arras, Nord-Pas-de-Calais, France

Co-Author(s)

Audrey Boulier, M.S.
– Scientific and innovation Manager Bioactives and Nutrition, Ingredia S.A., Arras, Nord-Pas-de-Calais, France
VC

Vincent Cremonese
– MérieuxNutrisciences

Disclosure(s):

Joanna Moro, PhD: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: To evaluate Lactium® perceived effectiveness in reducing symptoms related to stress and anxiety, a consumer study has been performed. The satisfaction data has been objectivize using scientific validated questionnaires.

Methods: This consumer study has been performed in three countries: France (n=122), USA (n=111) and China (n=105) with subjects suffering of moderate stress and sleep disorders. Lactium® 300 mg has been taken for 1 month, before bedtime. Satisfaction survey and three validated questionnaires were used to evaluate the impact of Lactium® on stress and sleep disorders: PSS-10 to assess stress levels, Spiegel questionnaire to estimate the quantity and quality of sleep, and the PSQI to evaluate sleep habits.

Results: After 1 month of supplementation, the overall satisfaction of the subjects was of 75% for France, 70% for China, and almost 90% for the USA. Lactium® significantly improves stress and sleep in France (73% and 69% of improvement, respectively), China (75% and 76%) and USA (85% and 86%). These results of perceived effectiveness have been confirmed by the results of the scientific validated questionnaires (PSS-10, PSQI and Spiegel questionnaire) showing a significant reduction in stress and sleep disorders.

Conclusions: After 1 month of treatment, Lactium® significantly improves stress and sleep disorders in subjects suffering of moderate stress and sleep disorders. Four out of five consumers are satisfied by the effectiveness of Lactium®.

Funding Sources: INGREDIA S.A.